ArticleDevelopmental medicine and child neurology2025
Autonomy in children and adolescents with visual impairment: Validation of the Visual Impairment Developmental Autonomy scale.
Article in Developmental medicine and child neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Functional vision promotes quality of life and socio-emotional functioning in visually impaired children and adolescents.PloS one · 2026Article
- The Visual Impairment Developmental Autonomy scale: Challenges in the assessment of children with visual impairment.Developmental medicine and child neurology · 2025Article
- Autonomy in children and adolescents with visual impairment: Validation of the Visual Impairment Developmental Autonomy scale.Developmental medicine and child neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimTo validate the Visual Impairment Developmental Autonomy (VIDA) scale, a questionnaire to assess the autonomy level of children with visual impairment.
methodThe primary outcome measures included internal consistency, convergent validity, cross-informant concordance, and descriptive statistics of autonomy profiles across three age groups (age 3-5 years; age 6-10 years; age 11-18 years). Internal consistency was assessed using Cronbach's Alpha coefficient. Convergent validity was evaluated against established measures such as the TNO-AZL Children's Quality of Life questionnaire (TACQOL) and the TNO-AZL Preschool Children's Quality of Life questionnaire (TAPQOL) using bivariate Pearson's correlation indexes.
resultsInternal consistency coefficients ranged between 0.708 and 0.938 across all subscales and age versions of the instrument. The VIDA subscales showed consistent correlations with comparable dimensions of the TACQOL/TAPQOL (correlations index >0.3). The cross-informant concordance was significant with weak-to-moderate effect sizes. Descriptive statistics showed different profiles of autonomy in the three age groups: clothing and orientation/mobility emerged as areas of vulnerability for adolescents. Visual acuity was significantly correlated with many VIDA scale scores, whereas no significant associations emerged with the quality of life.
interpretationThe VIDA scale is effective and reliable in providing both insights on the actual needs of children and quantitative measures of the visual impairment impact on everyday life. Autonomy level affects quality of life, whereas visual impairment does not.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.